Unproven drug of efficacy equivalency to reject insurance reimbursement.

The MOHW announced to legislate a provision on May 7 covering that 5,735 products manufactured by 186 companies of no drug efficacy equivalent tests being completed would not allow the medical insurance reimbursement unless at least a comparative dissolution test being proven until coming Oct after 6 month probation period.

The MOHW has encouraged drug companies to supply a high quality of d...